BioSpace News Archive

“As Trenton grows, the community knows.”

According to the National Institutes of Health, more than 65 percent of all humans are cow’s milk intolerant.

BioCad and Shanghai Pharmaceutical Holding entered into a Memorandum of Understanding to create two joint ventures for production, clinical development, registration, and marketing of several high-cost medicines based on monoclonal antibodies in the People’s Republic of China.

In the ongoing challenge to combat the almost always deadly brain cancers, namely Glioblastoma and melanoma metastasized to the brain, the pharmaceutical company Moleculin Biotech, Inc., (Nasdaq: MBRX) has initiated a Phase 1 clinical trial of a new first-in-class cancer drug candidate.

As part of its commitment to transform the patient and caregiver experience while delivering high quality care, Intermountain Healthcare today announced that it is the first integrated health system in the U.S. to implement a new needle-free blood collection system across all of its 22 hospitals.

Statement by Robin Koval, CEO & President, Truth Initiative® on FDA Commissioner Scott Gottlieb’s announcement that e-cigarette use among youth has hit epidemic proportions

Nexus Health Systems announces the launch of their Emerging Consciousness Program - also known as The Phoenix Project - for individuals with a disorder of consciousness post-brain injury.

The Hearing Loss Association of America (HLAA) invites you to join us for the 2018 Pennsylvania Walk4Hearing on October 21 at the Navy Yard in Philadelphia.

Presentation of advances from the groundbreaking I-SPY 2 TRIAL

Personalis, Inc., a leading provider of advanced genomic sequencing and analytics to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies, today announced that they are scheduled to present at the 3rd Annual Rational Combinations 360o event in Philadelphia, PA on September 13, 2018 at 1:50 PM ET.